NewsFeed
Headlines ASRM ESHRE FIGO ACOG Fertility and Sterility PCOS
November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Aumatma Simmons: How Is Your Practice Approaching Post-Miscarriage Diagnostic Protocols?
Aumatma Simmons/LinkedIn
Mar 22, 2026, 13:03

Aumatma Simmons: How Is Your Practice Approaching Post-Miscarriage Diagnostic Protocols?

Aumatma Simmons, Co-Founder, Chief Fertility Officer at Madre Fertility, shared a post on LinkedIn:

“Miscarriage investigation requires a fundamental shift in diagnostic focus from conception barriers to pregnancy maintenance factors. The pathophysiology differs significantly, necessitating targeted laboratory evaluation.

Autoimmune Assessment Protocol:

1. Thyroid Autoimmunity:

  • TPO and thyroglobulin antibodies increase miscarriage risk 2-4x, independent of thyroid hormone levels
  • Antineutrophil cytoplasmic antibody (ANCA) evaluation for vasculitic processes

2. Immunological Evaluation:

  • Natural Killer (NK) cell activity: 44% of women with unexplained recurrent loss show elevated levels (>18-20% vs. normal 5-15%)
  • Antiphospholipid antibodies: Associated with 90% pregnancy loss rates when untreated, reducible to 20% with intervention
  • Antinuclear antibodies (ANA) with specific pattern analysis

3. Reproductive Endocrine Assessment:

  • Comprehensive thyroid panel (TSH, Free T3, Free T4, all antibodies)
  • Luteal phase progesterone and cycle length evaluation
  • Luteal phases <10 days indicate insufficient progesterone support

4. Inflammatory Markers:

  • High-sensitivity C-reactive protein (hs-CRP)
  • Homocysteine levels
  • Chronic inflammation compromises endometrial receptivity

5. Nutritional Status:

  • Folate, B12, iron studies, vitamin D
  • Deficiencies directly correlate with increased pregnancy loss risk

Clinical Timing Considerations:
Optimal testing window: 3 months post-loss to avoid pregnancy-related hormonal interference.

Evidence-Based Insights:

  • 20% of recurrent pregnancy losses are immune-mediated
  • Immune dysfunction typically allows conception but prevents pregnancy maintenance
  • Th1/Th2 immune balance assessment reveals inflammatory vs. pregnancy-supportive states

Current Practice Gaps:
Standard protocols often delay comprehensive evaluation until after three losses, missing critical intervention opportunities.

Clinical Recommendation:
Comprehensive evaluation after two losses optimizes outcomes while reducing patient psychological burden and healthcare costs.

How is your practice approaching post-miscarriage diagnostic protocols?”

Proceed to the pages attached to the post.

Stay updated on all scientific advances in the field of fertility with Fertility News.

Aumatma Simmons B12 C-reactive protein Fertility Fertility News Folate Homocysteine Immune Dysfunction inflammatory markers iron Madre Fertility miscarriage Recurrent Pregnancy Loss Reproductive Endocrinology reproductive health Reproductive Medicine Thyroid Autoimmunity
NewsFeed